Property	Value
Status
Version
Ad File
Disable Ads Flag
Environment
Moat Init
Moat Ready
Contextual Ready
Contextual URL
Contextual Initial Segments
Contextual Used Segments
AdUnit
SubAdUnit
Custom Targeting
Ad Events
Invalid Ad Sizes

Notice to Our Valued Users

Elsevier has made the difficult decision to close PracticeUpdate permanently. There will be no new content published, effective immediately. Although we are all disappointed by this news, we are incredibly grateful for your engagement and support over the years.

We thank the Editorial Boards, Advisory Boards, and Editorial Contributors for their many years of dedication to educating the healthcare community. Our appreciation extends to the many contributors who have shared their valuable time and expertise to help us parse the latest research over the years.

We encourage you to explore our other offerings such as ScienceDirect and ClinicalKey, which continue to provide valuable insights and information to help you excel in your practice.

If you have any questions or need assistance, please see the FAQs section or contact the support team. Thank you for being a part of the PracticeUpdate community!

Colleague Insights

Conferences

Living Resources

Published in Congenital Heart Disease

Journal Scan / Research · April 28, 2020

Initial Experiences With A Novel Biodegradable Device for Percutaneous Closure of Atrial Septal Defects

Catheterization and Cardiovascular Interventions

Save Recommend

Sign in to PracticeUpdate

Only registered members have full access to PracticeUpdate content.

Sign in

Not a member?

Join for free

Additional Info

Article Citation

Catheterization and Cardiovascular Interventions

Initial Experiences With A Novel Biodegradable Device for Percutaneous Closure of Atrial Septal Defects: From Preclinical Study to First-in-Human Experience

Catheter Cardiovasc Interv 2020 Feb 01;95(2)282-293, YF Li, YM Xie, J Chen, BN Li, ZF Xie, SS Wang, ZW Zhang

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Notice to Our Valued Users

Congenital Heart Disease

Initial Experiences With A Novel Biodegradable Device for Percutaneous Closure of Atrial Septal Defects

Additional Info

Initial Experiences With A Novel Biodegradable Device for Percutaneous Closure of Atrial Septal Defects: From Preclinical Study to First-in-Human Experience

Further Reading

Dr. Petros Grivas on Switching Jobs: Part 3

Results of the FUEL Trial

Disparities in CHD Mortality Based on Proximity to a Specialized Pediatric Cardiac Center

Outcomes in Anomalous Aortic Origin of a Coronary Artery Following a Prospective Standardized Approach

Dr. Petros Grivas on Switching Jobs: Part 2

Heart Transplantation and In-Hospital Outcomes in Adult Congenital Heart Disease Patients With Fontan

Dr. Petros Grivas on Switching Jobs: Part 1

Management of People With a Fontan Circulation

Appropriate Use Criteria for Multimodality Imaging During the Follow-Up Care of Patients With Congenital Heart Disease

Trends in Infant Mortality After TAPVR Repair Over 18 Years and Impact of Hospital Surgical Volume

Global, Regional, and National Burden of Congenital Heart Disease, 1990–2017

Recently Updated